天然产物研究与开发 ›› 2025, Vol. 37 ›› Issue (4): 694-706.doi: 10.16333/j.1001-6880.2025.4.012 cstr: 32307.14.1001-6880.2025.4.012

• 开发研究 • 上一篇    下一篇

硫代葡萄糖苷治疗炎症性肠病的作用机制研究

陈  澍1,望  宇4,毛旭文2,3*   

  1. 1新疆医科大学中医学院,乌鲁木齐 8300112新疆医科大学药学院,乌鲁木齐 8300003新疆天然药物活性组分与释药技术重点实验室,乌鲁木齐 8300004新疆医科大学第三临床医学院,乌鲁木齐 830011

  • 出版日期:2025-04-30 发布日期:2025-04-27
  • 基金资助:
    新疆维吾尔自治区科学技术厅自然科学基金面上项目(2022D01C190);新疆医科大学第15期大学生创新训练基金(S202010760036)

Study on the mechanism of glucosinolate in treating inflammatory bowel disease

CHEN Shu1, WANG Yu4, MAO Xu-wen2,3*   

  1. 1College of Traditional Chinese Medicine,Xinjiang Medical University,Urumqi 830011,China; 2College of Pharmacy,Xinjiang Medical University,Urumqi 830000,China; 3Key Laboratory of Active Component and Drug Delivery Technology of Natural Medicines,Xinjiang,Urumqi 830000,China; 4Third Clinical Medical College,Xinjiang Medical University,Urumqi 830011,China
  • Online:2025-04-30 Published:2025-04-27

摘要:

研究结球甘蓝中硫代葡萄糖苷(glucosinolatesGSL;简称硫苷)治疗炎症性肠病(inflammatory bowel diseaseIBD)的作用机制。利用公共数据库获得IBDGSL的作用靶点,将二者取交集,构建蛋白互作网络,利用GOKEGG富集分析其治疗IBD的潜在靶点。通过分子对接验证GSL中的活性单体成分3-吲哚基甲基硫苷(glucobrassicinGBC)与核心靶点之间结合能。用葡聚糖硫酸钠建立IBD小鼠模型,检测其疾病活动指数评分、肠通透性、肠组织肿瘤坏死因子-α(tumor necrosis factor-αTNF-α)等细胞因子水平。使用试剂盒检测人结直肠腺癌细胞增殖活性,ELISA检测脂多糖(lipopolysaccharideLPS)诱导下该细胞释放TNF-α和白细胞介素10(interleukin-1IL-10)水平。得到IBDGSL交集靶点92个;GO功能分析表明调节炎症反应、调节激酶活性等多种生物过程参与IBD发展进程,获得了拓扑异构酶α(topoisomerase II alphaTOP2A)、细胞周期蛋白依赖性激酶1(cyclin-dependent kinase 1CDK1)、细胞色素P4502C9(cytochrome P4502C9CYP2C19)10GSL治疗IBD的核心靶点;KEGG富集相关性较高的通路为TRP通道炎症介质调节通路等;分子对接显示GBC与核心靶点有较好的结合活性。中、高剂量GSL组可减缓小鼠体重下降幅度并改善小鼠稀便和便血等情况,显著降低模型组DAI评分(P<0.001);降低小鼠肠组织TNF-α等细胞因子水平(P<0.001),升高IL-10水平(P<0.001)。在20~300 μmol/L浓度范围内,GSL促进人结直肠腺癌细胞增殖,抑制LPS诱导的TNF-α分泌,升高IL-10水平。以上结果表明,GSL可能通过抑制TOP2ACDK1蛋白表达,减轻小鼠肠道的炎性反应,缓解炎症性肠病症状。

关键词: 硫代葡萄糖苷, 炎症性肠病, 结球甘蓝, 分子对接

Abstract:

The purpose of this paper is to explore the mechanism of action of glucosinolates (GSL) in common head cabbage for the treatment of inflammatory bowel disease (IBD).Using public databases,this study obtained the targets of IBD and GSL,took the intersection of the two,constructed the protein interactions network,and analyzed their potential targets for the treatment of IBD using GO and KEGG enrichment.The binding energy between glucobrassicin (GBC),the active monomer component of GSL,and the core target was verified by molecular docking.Mice models of IBD were established with dextran sodium sulfate,and their disease activity index scores,intestinal permeabilities,intestinal tissue tumor necrosis factor-α (TNF-α) and other cytokine levels were detected.The proliferative activity of human colorectal adenocarcinoma cells was detected using a kit,and the levels of TNF-α and interleukin-1 (IL-10) released from this cell induced by lipopolysaccharide (LPS) were detected by ELISA.Ninety-two intersection targets of IBD and GSL were obtained.GO functional analysis indicated that various biological processes,such as regulation of inflammatory response and modulation of kinase activity,were involved in the developmental process of IBD.Ten targets for the treatment of IBD by GSL,such as topoisomerase Ⅱα (TOP2A),cell cycle protein-dependent kinase 1 (CDK1),cytochrome P4502C9 (CYP2C19) were obtained;In the KEGG enrichment analysis,the pathways with higher relevance included the TRP channel inflammatory mediator-regulated pathway.Molecular docking showed that GBC had better binding activity with the core targets.The medium and high GSL groups slowed down the weight loss and improved the condition of mice,such as loose stool and blood in stool,and significantly reduced the DAI score of the model group (P<0.001),lowered the levels of cytokines,such as TNF-α,in the intestinal tissues of the mice (P<0.001),and elevated the levels of IL-10 (P<0.001).In the concentration range of 20-300 μmol/L,GSL promoted the proliferation of human colorectal adenocarcinoma cells,inhibited LPS-induced TNF-α secretion,and elevated IL-10 levels.The above results suggested that GSL could attenuate the inflammatory response of the mouse intestine and alleviate the symptoms of inflammatory bowel disease by inhibiting TOP2A and CDK1 protein expression.

Key words:

glucosinolate, inflammatory bowel disease, common head cabbage, molecular docking

中图分类号:  R284.1 R319